SCHEMBL1841125

SCHEMBL1841125

COc1cc(CCC(=O)c2ccccc2O)ccc1O

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.63
OR51E2 Q9H255 1/20 0.63
CYP19A1 P11511 2/20 0.60
TRPV1 Q8NER1 1/20 0.56
CYP1A2 P05177 1/20 0.55
CYP3A4 P08684 1/20 0.55
CYP2C8 P10632 1/20 0.55
CYP2C9 P11712 1/20 0.55
CYP2B6 P20813 1/20 0.55
CYP2C19 P33261 1/20 0.55
TAAR1 Q96RJ0 2/20 0.55
TSHR P16473 2/20 0.55
MAPK1 P28482 1/20 0.55
GAA P10253 3/20 0.55
POLB P06746 1/20 0.55
LMNA P02545 1/20 0.54
GLA P06280 1/20 0.54
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
ALDH1A1 P00352 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29828287 0.92 KMT2A (0.61) ALOX5OR51E2CYP19A1GAAMEN1
SCHEMBL10829624 0.92 KMT2A (0.61) ALOX5OR51E2CYP19A1GAAMEN1
SCHEMBL10328456 0.89 CYP19A1 (0.65) ALOX5OR51E2CYP19A1TRPV1CYP1A2
SCHEMBL7194055 0.86 CYP19A1 (0.56) ALOX5CYP19A1GAALMNAMEN1
SCHEMBL31511909 0.85 MEN1 (0.67) ALOX5OR51E2CYP19A1CYP1A2CYP3A4
SCHEMBL1840837 0.85 MEN1 (0.67) ALOX5OR51E2CYP19A1CYP1A2CYP3A4
SCHEMBL30834837 0.84 ALOX5 (0.65) ALOX5OR51E2CYP19A1TRPV1CYP1A2
SCHEMBL1843348 0.84 ALOX5 (0.65) ALOX5OR51E2CYP19A1TRPV1CYP1A2
SCHEMBL20017691 0.84 ALOX5 (0.65) ALOX5OR51E2TRPV1CYP1A2CYP3A4
SCHEMBL15329262 0.83 ESRRG (0.60) ALOX5OR51E2CYP1A2CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1972203-B1 Use of 4-hydroxychalkon derivatives for masking an unpleasant taste SYMRISE AG (DE) 2012-05-16 EP claimed
EP-1977655-B1 Aroma compositions of alkamides with hesperetin and/or 4-hydroxydihydrochalkones and their salts for reinforcing sweet sensory impressions SYMRISE AG (DE) 2011-05-18 EP claimed
US-20100233102-A1 USE OF 4-HYDROXYDIHYDROCHALCONES AND THEIR SALTS FOR ENHANCING AN IMPRESSION OF SWEETNESS SYMRISE GMBH & CO. KG (DE) 2010-09-16 US claimed
EP-1998636-B1 USE OF 4-HYDROXYDIHYDROCHALCONES AND THEIR SALTS FOR ENHANCING AN IMPRESSION OF SWEETNESS SYMRISE GMBH & CO KG (DE) 2010-05-19 EP claimed
EP-1998636-A1 USE OF 4-HYDROXYDIHYDROCHALCONES AND THEIR SALTS FOR ENHANCING AN IMPRESSION OF SWEETNESS Symrise GmbH & Co. KG (DE) 2008-12-10 EP claimed
EP-1977655-A1 Aroma compositions of alkamides with hesperetin and/or 4-hydroxydihydrochalkones and their salts for reinforcing sweet sensory impressions Symrise GmbH & Co. KG (DE) 2008-10-08 EP claimed
US-20080242740-A1 AROMA COMPOSITIONS OF ALKAMIDES WITH HESPERETIN AND/OR 4-HYDROXYDIHYDROCHALCONES AND SALTS THEREOF FOR ENHANCING SWEET SENSORY IMPRESSIONS SYMRISE GMBH & CO. KG (DE) 2008-10-02 US claimed
EP-1972203-A1 Use of 4-hydroxychalkon derivatives for masking an unpleasant taste Symrise GmbH & Co. KG (DE) 2008-09-24 EP claimed
US-20080227867-A1 USE OF 4-HYDROXYCHALCONE DERIVATIVES FOR MASKING AN UPLEASANT TASTE SYMRISE GMBH & CO. KG (DE) 2008-09-18 US claimed
WO-2007107596-A1 USE OF 4-HYDROXYDIHYDROCHALCONES AND THEIR SALTS FOR ENHANCING AN IMPRESSION OF SWEETNESS SYMRISE GMBH & CO. KG (DE) 2007-09-27 WO claimed
US-9445606-B2 Use of 4-hydroxydihydrochalcones and their salts for enhancing an impression of sweetness SYMRISE AG (DE) 2016-09-20 US disclosed
US-9445606-B2 Use of 4-hydroxydihydrochalcones and their salts for enhancing an impression of sweetness SYMRISE AG (DE) 2016-09-20 US disclosed
US-9445606-B2 Use of 4-hydroxydihydrochalcones and their salts for enhancing an impression of sweetness SYMRISE AG (DE) 2016-09-20 US disclosed
US-9198451-B2 Aroma composition to reduce or suppress undesirable bitter and astringent taste impressions of sweeteners SYMRISE AG (DE) 2015-12-01 US disclosed
US-8778987-B2 Use of 4-hydroxychalcone derivatives for masking an unpleasant taste SYMRISE AG (DE) 2014-07-15 US disclosed
US-20080227867-A1 USE OF 4-HYDROXYCHALCONE DERIVATIVES FOR MASKING AN UPLEASANT TASTE SYMRISE GMBH & CO. KG (DE) 2008-09-18 US disclosed
US-20080227867-A1 USE OF 4-HYDROXYCHALCONE DERIVATIVES FOR MASKING AN UPLEASANT TASTE SYMRISE GMBH & CO. KG (DE) 2008-09-18 US disclosed
US-20080227867-A1 USE OF 4-HYDROXYCHALCONE DERIVATIVES FOR MASKING AN UPLEASANT TASTE SYMRISE GMBH & CO. KG (DE) 2008-09-18 US disclosed
WO-2007107596-A1 USE OF 4-HYDROXYDIHYDROCHALCONES AND THEIR SALTS FOR ENHANCING AN IMPRESSION OF SWEETNESS SYMRISE GMBH & CO. KG (DE) 2007-09-27 WO disclosed
WO-2007107596-A1 USE OF 4-HYDROXYDIHYDROCHALCONES AND THEIR SALTS FOR ENHANCING AN IMPRESSION OF SWEETNESS SYMRISE GMBH & CO. KG (DE) 2007-09-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080227867-A1 USE OF 4-HYDROXYCHALCONE DERIVATIVES FOR MASKING AN UPLEASANT TASTE TAS2R45, TAS2R43, TAS2R30 ALOX5 386/4885OR51E2 30/4885CYP19A1 4132/4885
US-20080242740-A1 AROMA COMPOSITIONS OF ALKAMIDES WITH HESPERETIN AND/OR 4-HYDROXYDIHYDROCHALCONES AND SALTS THEREOF FOR ENHANCING SWEET SENSORY IMPRESSIONS TAS2R5, TAS2R20, TAS2R40 ALOX5 1963/4885OR51E2 35/4885CYP19A1 1036/4885
US-20100233102-A1 USE OF 4-HYDROXYDIHYDROCHALCONES AND THEIR SALTS FOR ENHANCING AN IMPRESSION OF SWEETNESS TAS2R4, TAS2R1, TAS2R20 ALOX5 2788/4885OR51E2 33/4885CYP19A1 2966/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.